Rep. John James

Maddy summaryThe AGOA Extension and Enhancement Act of 2024 extends the African Growth and Opportunity Act (AGOA) through September 30, 2037, maintaining duty-free access for eligible sub-Saharan African countries to the U.S. market. It requires beneficiary countries to develop and publish biennial utilization strategies outlining how they will better leverage AGOA benefits, with the U.S. providing trade capacity building assistance for implementation. The bill establishes a biennial review process to assess countries' ongoing eligibility based on criteria including anti-corruption standards, human rights compliance, and terrorism cooperation. It also creates a mandatory graduation process for high-income countries that maintain high-income status for five consecutive years, with limited exceptions for potential free trade agreement negotiations. The legislation includes new reporting requirements for the U.S. government on AGOA implementation and potential trade agreements with sub-Saharan African nations.

Maddy summaryThe Pharmacists Fight Back Act (HR 9096) sets new rules for Pharmacy Benefits Managers (PBMs) working with federal health care programs like Medicare Part D and Medicaid. It requires PBMs to reimburse in-network pharmacies at a rate covering the drug's actual cost plus a small fee (capped at $25), and to reduce patient cost-sharing by at least 80% of rebates received from drug manufacturers. The bill bans PBMs from steering patients to specific pharmacies, charging patients more than pharmacies are paid, or using rebates to lower pharmacy payments after claims are processed. It also mandates public reporting of drug pricing data to improve transparency, ensuring patients and pharmacies receive fairer treatment under federal health programs.

Maddy summaryThis bill requires Medicare Advantage plans to implement electronic prior authorization systems by 2027 and publish detailed data on their approval and denial rates for medical services by 2026. It directly affects Medicare Advantage plans (private insurers offering Medicare coverage) and their enrollees (seniors 65+), mandating transparency about prior authorization decisions, processing times, and appeal outcomes. Key provisions include requiring plans to report annual statistics on request approvals/denials, average processing times, and use of technology, with this data published publicly by the Centers for Medicare & Medicaid Services. The bill also sets timelines for plan responses to prior authorization requests and mandates reports to Congress on implementation and impacts.

Maddy summaryThe Essential Caregivers Act of 2024 requires nursing homes and similar facilities to allow residents to designate essential caregivers who provide emotional support or assistance with daily activities. During emergencies when regular visitation is restricted, facilities must permit at least one essential caregiver access to residents daily and cannot deny access without following specific procedures. Facilities may deny access for a maximum of 7 days during emergencies (or 14 days with state approval), and must provide a written explanation and appeal process if access is denied. The bill establishes a 48-hour appeal process for residents and caregivers to challenge denials, with facilities required to prove violations during appeals. This law applies to Medicare skilled nursing facilities, Medicaid nursing facilities, intermediate care facilities, and certain inpatient rehabilitation facilities.

Maddy summaryHR 8075, the Improving Access to Home Dialysis Act of 2024, creates a new "staff-assisted home dialysis" program to help patients who need in-person support at home for kidney dialysis treatments. It requires Medicare to add a payment increase for providers who offer this service, where trained staff (like nurses or technicians) assist patients during their initial home dialysis setup, recovery from hospitalization, or temporary needs due to illness or caregiver unavailability. The bill also mandates patient education on this option and establishes training methods, including telehealth and group sessions, to help patients and caregivers learn home dialysis skills. It further requires studies on racial disparities in home dialysis access and the development of a patient decision tool to help choose dialysis settings. The law directly affects Medicare dialysis patients needing assistance, their care providers, and Medicare's payment structure for home dialysis services.

Maddy summaryHR 8018, the ABC Act, requires Medicare, Medicaid, CHIP, and Social Security Administration to review their eligibility processes, forms, and communications to simplify interactions for family caregivers. It targets reducing duplicate paperwork, improving website accessibility (including ADA compliance), and enhancing staff communication - such as shorter call waits and multilingual support - to better serve caregivers supporting individuals enrolled in these programs. The review must include input from caregivers and organizations, with results reported to Congress within one year. This procedural bill does not change program benefits but mandates systemic improvements to reduce administrative burdens.

Maddy summaryThe Patient’s Choice Act of 2024 prohibits federal agencies from implementing or enforcing a 2023 proposed rule that would have shortened the maximum duration of short-term health insurance plans. It blocks efforts to reduce the current allowable term for these plans below the existing standard, ensuring they can still be offered with an initial term under 12 months and a total duration of up to 3 years (including renewals). This bill directly affects health insurance issuers and consumers who rely on short-term plans as a temporary coverage option. The legislation maintains the current regulatory framework without altering plan requirements or creating new benefits.

Maddy summaryThis bill changes the negotiation period for small-molecule drugs under the federal Drug Price Negotiation Program from 7 years to 11 years, matching the existing 11-year period for biologic drugs. It directly affects drug manufacturers participating in the program by extending the timeframe for price negotiations with the government. The amendment applies to all small-molecule drugs covered under the program, creating a uniform negotiation timeline for both drug types. The change takes effect as if included in the Inflation Reduction Act of 2022.

Maddy summaryHR 5408, the SSI Savings Penalty Elimination Act, increases the resource limits for Supplemental Security Income (SSI) program eligibility. It raises the individual resource limit from $2,250 to $20,000 (and the couple limit from $1,500 to $10,000) for 2023, with future annual increases tied to inflation using the Consumer Price Index. This change directly affects low-income SSI recipients who currently lose benefits if their savings exceed the current thresholds. The key mechanism is raising these savings limits to reduce the "penalty" for saving modest amounts, while maintaining program integrity through automatic inflation adjustments.

Maddy summaryHR 3561, the PATIENT Act of 2023, requires hospitals, health insurance plans, and pharmacy benefit managers to publicly disclose detailed pricing information for healthcare services and drugs. Hospitals must publish standard charges for 300+ shoppable services, including gross charges, payer-specific negotiated rates, and discounted cash prices, with updates required annually. Health plans must provide real-time information on in-network rates, cost sharing, deductibles, and prior authorization requirements for covered services. The bill establishes enforcement mechanisms, including civil monetary penalties for non-compliance, with fines ranging from $300 per day for small hospitals to $5 million for large hospitals that fail to comply with the transparency requirements.